Dr. Folatomi Agbe-Davies, MD

Dr. Agbe-Davies practices at Georgia Interventional Pain - Q, LLC in Braselton, Georgia.

Dr. Agbe-Davies' NPI, 1073805891, was assigned on May 12, 2011. Dr. Agbe-Davies holds Georgia license 87755.

Dr. Agbe-Davies' primary practice is Georgia Interventional Pain - Q, LLC, at 5670 Old Winder Hwy, Braselton, GA 30517 in Jackson County. The practice phone is (770) 962-3642.

Dr. Agbe-Davies' primary practice is Georgia Interventional Pain - Q, LLC in Braselton, Georgia. Dr. Agbe-Davies is also affiliated with Northeast Georgia Medical Center Gainesville. The medical group on file is Kidney Care Center of Georgia. Dmand AI also links Dr. Agbe-Davies to 3 more hospitals, 2 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agbe-Davies practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Agbe-Davies' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Agbe-Davies is board certified in internal medicine by the American Board of Internal Medicine. Dr. Agbe-Davies is licensed in Georgia.

CMS data shows 1,914 Medicare services from Dr. Agbe-Davies across 9 procedure codes in 2024, for 538 Medicare patients. Medicare paid $119,312 for them.

CMS counts 538 Medicare patients who saw Dr. Agbe-Davies in 2024. The largest group is 65 to 74, with 193 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 3.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agbe-Davies' median patient age at 72, with 51% women.

In 2024, Dr. Agbe-Davies wrote 1,074 Medicare Part D claims for 278 patients. 90% of them were for generic drugs. CMS names the drug for 905 of them, across 23 drugs with 11 or more claims each, at $63,195 in total drug cost. In 2023, CMS named 586 claims across 18 drugs.

Dr. Agbe-Davies accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agbe-Davies as offering telehealth.

CMS Open Payments shows 205 general payments to Dr. Agbe-Davies from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Amgen Inc. paid the most, $675.